Enzyme kinetics hypothesis to explain the U-shaped risk curve for prostate cancer vs. 25-hydroxyvitamin D in Nordic countries

被引:23
作者
Vieth, R
机构
[1] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada
关键词
D O I
10.1002/ijc.20218
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:468 / 468
页数:1
相关论文
共 8 条
[1]  
Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt
[2]  
60::AID-IJC11&gt
[3]  
3.0.CO
[4]  
2-B
[5]   Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case-control study in the Nordic countries [J].
Tuohimaa, P ;
Tenkanen, L ;
Ahonen, M ;
Lumme, S ;
Jellum, E ;
Hallmans, G ;
Stattin, P ;
Harvei, S ;
Hakulinen, T ;
Luostarinen, T ;
Dillner, J ;
Lehtinen, M ;
Hakama, M .
INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (01) :104-108
[6]   ROLE OF 25-HYDROXYVITAMIN-D3 DOSE IN DETERMINING RAT 1,25-DIHYDROXYVITAMIN-D3 PRODUCTION [J].
VIETH, R ;
MCCARTEN, K ;
NORWICH, KH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (05) :E780-E789
[7]   MODERATE VITAMIN-D3 SUPPLEMENTATION LOWERS SERUM 1,25-DIHYDROXY-VITAMIN-D3 IN RATS [J].
VIETH, R ;
MILOJEVIC, S .
NUTRITION RESEARCH, 1995, 15 (05) :725-731
[8]  
YOUNG MV, IN PRESS CARCINOGENE